Paracetamol and the placebo effect in osteoarthritis trials: A missing link?

Pain Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Zeidler, Henning ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873817294     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2011/696791     Document Type: Review

References (33)

1. Altman R. D., Hochberg M. C., Moskowitz R. W., Schnitzer T. J., Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis and Rheumatism 2000 43 9 1905 1915 10.1002/1529-0131(200009)43:9-1905::AID-ANR1>3.0.CO;2-P
2. Jordan K. M., Arden N. K., Doherty M., Bannwarth B., Bijlsma J. W. J., Dieppe P., Gunther K., Hauselmann H., Herrero-Beaumont G., Kaklamanis P., Lohmander S., Leeb B., Lequesne M., Mazieres B., Martin-Mola E., Pavelka K., Pendleton A., Punzi L., Serni U., Swoboda B., Verbruggen G., Zimmerman-Gorska I., Dougados M., EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Annals of the Rheumatic Diseases 2003 62 12 1145 1155 2-s2.0-10744224265 10.1136/ard.2003.011742 (Pubitemid 37500619)
3. Zhang W., Doherty M., Arden N., Bannwarth B., Bijlsma J., Gunther K. P., Hauselmann H. J., Herrero-Beaumont G., Jordan K., Kaklamanis P., Leeb B., Lequesne M., Lohmander S., Mazieres B., Martin-Mola E., Pavelka K., Pendleton A., Punzi L., Swoboda B., Varatojo R., Verbruggen G., Zimmermann-Gorska I., Dougados M., EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases 2005 64 5 669 681 2-s2.0-20244375984 10.1136/ard.2004.028886 (Pubitemid 40559291)
4. Zhang W., Doherty M., Leeb B. F., Alekseeva L., Arden N. K., Bijlsma J. W., Dinçer F., Dziedzic K., Häuselmann H. J., Herrero-Beaumont G., Kaklamanis P., Lohmander S., Maheu E., Martín-Mola E., Pavelka K., Punzi L., Reiter S., Sautner J., Smolen J., Verbruggen G., Zimmermann-Górska I., EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases 2007 66 3 377 388 2-s2.0-34147201733 10.1136/ard.2006.062091 (Pubitemid 46579641)
5. Zhang W., Robertson J., Jones A. C., Dieppe P. A., Doherty M., The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Annals of the Rheumatic Diseases 2008 67 12 1716 1723 2-s2.0-56049109217 10.1136/ard.2008.092015
6. Towheed T. E., Maxwell L., Judd M. G., Catton M., Hochberg M. C., Wells G., Acetaminophen for osteoarthritis. Cochrane Database of Systematic Reviews 2006 1 CD004257 2-s2.0-33645506854
7. Zhang W., Jones A., Doherty M., Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Annals of the Rheumatic Diseases 2004 63 8 901 907 2-s2.0-3242685960 10.1136/ard.2003.018531 (Pubitemid 38961912)
8. Williams H. J., Ward J. R., Egger M. J., Neuner R., Brooks R. H., Clegg D. O., Field E. H., Skosey J. L., Alarcon G. S., Willkens R. F., Paulus H. E., Russell I. J., Sharp J. T., Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis and Rheumatism 1993 36 9 1196 1206 2-s2.0-0027445980 10.1002/art.1780360904 (Pubitemid 23303110)
9. García Rodríguez L. A., Hernández-Díaz S., Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 2001 12 5 570 576 2-s2.0-0034892763 10.1097/00001648-200109000-00018 (Pubitemid 32762000)
10. Hróbjartsson A., Gotzsche P. C., Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. The New England Journal of Medicine 2001 344 21 1594 1602 2-s2.0-0342902205 10.1056/NEJM200105243442106 (Pubitemid 32479913)
11. Hróbjartsson A., Gotzsche P. C., Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. Journal of Internal Medicine 2004 256 2 91 100 2-s2.0-3242887419 10.1111/j.1365-2796.2004.01355.x (Pubitemid 38998255)
12. Vase L., Riley J. L., Price D. D., A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 2002 99 3 443 452 2-s2.0-0036803108 10.1016/S0304-3959(02)00205-1 (Pubitemid 35284275)
13. Miller F. G., Rosenstein D. L., The nature and power of the placebo effect. Journal of Clinical Epidemiology 2006 59 4 331 335 2-s2.0-33645026920 10.1016/j.jclinepi.2005.12.001
14. Breidert M., Hofbauer K., Placebo: misunderstandings and prejudices. Deutsches Arzteblatt 2009 106 46 751 755 2-s2.0-76149125776 10.3238/arztebl. 2009.0751
15. Bijlsma J. W. J., Welsing P. M. J., The art of medicine in treating osteoarthritis: I will please. Annals of the Rheumatic Diseases 2008 67 12 1653 1655 2-s2.0-56749174704 10.1136/ard.2008.097006
16. The rules governing medicinal products in the European Union. Volume 10. Clinical Trials. Notice to Applicants. Chapter V. Additional Information. Questions and Answers. http://ec.europa.eu/health/files/pharmacos/docs/doc2006/ 07-2006/def-imp-2006-07-27-en.pdf
17. Fleischmann R., Tannenbaum H., Patel N. P., Notter M., Sallstig P., Reginster J. Y., Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: a randomised controlled trial in patients with osteoarthritis. BMC Musculoskeletal Disorders 2008 9, article 32 2-s2.0-42249108860 10.1186/1471-2474-9-32 (Pubitemid 351551366)
18. Guidance for industry. Clinical development programs for drugs, devices, and biological products intended for the treatment of osteoarthritis. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM071577.pdf
19. Committee for medicinal products for human use. Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/WC500003440.pdf
20. Frestedt J. L., Kuskowski M. A., Zenk J. L., A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: a randomised, placebo controlled pilot study. Nutrition Journal 2009 8 1, article 7 2-s2.0-60849121733 10.1186/1475-2891-8-7
21. Karlsson J., Pivodic A., Aguirre D., Schnitzer T. J., Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee. Journal of Rheumatology 2009 36 6 1290 1297 2-s2.0-67149147431 10.3899/jrheum.081011
22. Jacquet A., Girodet P. O., Pariente A., Forest K., Mallet L., Moore N., Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial. Arthritis Research & Therapy 2009 11 6 R192 2-s2.0-77952506057
23. Krüger K., Klasser M., Mössinger J., Becker U., Oxaceprol-a randomised, placebo-controlled clinical study in osteoarthritis with a non-conventional non-steroidal anti-inflammatory drug. Clinical and Experimental Rheumatology 2007 25 1 29 34 2-s2.0-33947583913 (Pubitemid 46477482)
24. Puopolo A., Boice J. A., Fidelholtz J. L., Littlejohn T. W., Miranda P., Berrocal A., Ko A., Cichanowitz N., Reicin A. S., A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis. Osteoarthritis and Cartilage 2007 15 12 1348 1356 2-s2.0-35748934466 10.1016/j.joca.2007.05.022 (Pubitemid 350048566)
25. Reginster J. Y., Malmstrom K., Mehta A., Bergman G., Ko A. T., Curtis S. P., Reicin A. S., Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis. Annals of the Rheumatic Diseases 2007 66 7 945 951 2-s2.0-34347242059 10.1136/ard.2006.059162 (Pubitemid 46999799)
26. Sawitzke A. D., allen.sawitzke@hsc.utah.edu Shi H., Finco M. F., Dunlop D. D., Harris C. L., Singer N. G., Bradley J. D., Silver D., Jackson C. G., Lane N. E., Oddis C. V., Wolfe F., Lisse J., Furst D. E., Bingham C. O., Reda D. J., Moskowitz R. W., Williams H. J., Clegg D. O., Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Annals of the Rheumatic Diseases 2010 69 8 1459 1464 10.1136/ard.2009.120469
27. Schnitzer T. J., Kivitz A., Frayssinet H., Duquesroix B., Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study. Osteoarthritis and Cartilage 2010 18 5 629 639 2-s2.0-77952547893 10.1016/j.joca.2009.12.013
28. Yang K. G. A., Raijmakers N. J. H., van Arkel E. R. A., Caron J. J., Rijk P. C., Willems W. J., Zijl J. A. C., Verbout A. J., Dhert W. J. A., Saris D. B. F., Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. Osteoarthritis and Cartilage 2008 16 4 498 505 2-s2.0-41249087458 10.1016/j.joca.2007.07.008 (Pubitemid 351444567)
29. Thorne C., Beaulieu A. D., Callaghan D. J., O'Mahony W. F., Bartlett J. M., Knight R., Kraag G. R., Akhras R., Piraino P. S., Eisenhoffer J., Harsanyi Z., Darke A. C., A randomized, double-blind, crossover comparison of the efficacy and safety of oral controlled-release tramadol and placebo in patients with painful osteoarthritis. Pain Research and Management 2008 13 2 93 102 2-s2.0-45749113760 (Pubitemid 351865291)
30. Price D. D., Finniss D. G., Benedetti F., A comprehensive review of the placebo effect: recent advances and current thought. Annual Review of Psychology 2008 59 565 590 2-s2.0-41549119566 10.1146/annurev.psych.59.113006.095941
31. Finniss D. G., Kaptchuk T. J., Miller F., Benedetti F., Biological, clinical, and ethical advances of placebo effects. The Lancet 2010 375 9715 686 695 2-s2.0-76749169724 10.1016/S0140-6736(09)61706-2
32. Clegg D. O., Reda D. J., Harris C. L., Klein M. A., O'Dell J. R., Hooper M. M., Bradley J. D., Bingham C. O., Weisman M. H., Jackson C. G., Lane N. E., Cush J. J., Moreland L. W., Schumacher H. R., Oddis C. V., Wolfe F., Molitor J. A., Yocum D. E., Schnitzer T. J., Furst D. E., Sawitzke A. D., Shi H., Brandt K. D., Moskowitz R. W., Williams H. J., Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. The New England Journal of Medicine 2006 354 8 795 808 2-s2.0-33344461287 10.1056/NEJMoa052771 (Pubitemid 43290918)
33. Farmer K. C., Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics 1999 21 6 1074 1090 2-s2.0-0032796185 10.1016/S0149-2918(99)80026-5 (Pubitemid 29326165)